Past Events

Nanion Past Events

You are viewing the list of past events.
Switch to upcoming events instead.


24.09.2017 | HTS in Cardiac Safety

170923 Event image SPS Nanion SymposiumConference Venue: Maritim Hotel Berlin, Germany

Niels Fertig, Sonja Stölzle-Feix, Frank Henrichsen and Elena Dragicevic are looking forward to meeting you on Sunday 24th September, 4:00 PM - 6:30 PM in the Maritim Hotel Salon 15 / Paris (1st floor).

Confirmed Speaker:

Said el Haou, Metrion Biosciences:
In depth profiling of human iPSC-CM – from electrophysiology to phenotypic assays"

Matt Burnham, AstraZeneca:
Impedance and field potential in 3D: cardiomyocyte co-culture spheroids and the CardioExcyte96 platform"

Abstract:
In vitro three-dimensional and co-culture cell models can provide more physiologically relevant data than conventional 2D approaches. We explored novel label-free methods to record functional data from actively beating, 3D spheroid co-cultures of iPSC cardiomyocytes. Using the Nanion CardioExcyte® 96 platform, designed for recordings from 2D iPSC cardiomyocytes monolayers, the electrical activity (extracellular field potential) and beating pattern (impedance) of cardiomyocyte spheroids could be detected. To facilitate the essential spheroid-to-electrode positioning, magnetic nano-particle based approaches were explored. Treatment with compounds known to affect beat rate and field potential duration generated appropriate results in the 3D system. A cumulative-dosing approach was developed to demonstrate a drug discovery work flow suitable for profiling studies. In comparison to a conventional contractility assay approach (2D FLIPR), significant advantages in reduced iPSC usage and cost (approximately eight-fold) and increased through-put were demonstrated. The high through-put of the system was leveraged to profile the functional phenotype of various iPSC and fibroblast co-culture types under different experimental conditions. Phenotype profiling revealed substantial differences amongst co-culture types, such as in beat amplitude and responses to E-4031. Electrical pacing revealed true inotropic responses (increased beat amplitude at constant beat rate) in some conditions. In summary, recording functional data from the 3D phenotype of spheroid co-cultures of electrically-active and beating cardiomyocytes in a screening platform has been achieved which may improve the predictivity of Safety assays and facilitate a better understanding of 3D co-culture phenotypes.

Takasuna Kiyoshi, Daiichi Sankyo/ Novare:
Comprehensive in vitro cardiac safety assessment using human stem cell technology (CSAHi: HEART initiative) -The second stage"
1) Discovery Pharmacokinetics Research Group, Pharmaceutical and Biomedical Analysis Department, Daiichi Sankyo Rd Novare Co., Ltd.
2) Consortium for Safety Assessment using Human iPS Cells (CSAHi): HEART Team

Abstract:
Since 2013, we have organized the Consortium for Safety Assessment using Human iPS Cells (CSAHi; http://csahi.org/en/) in Japan to verify the application of human iPS/ES cell-derived cardiomyocytes in drug safety evaluation. The definitive goal of the CSAHi HEART Team has been to propose comprehensive screening strategies to predict a diverse range of cardiotoxicities (arrhythmia, contractile dysfunction, and cardiomyocyte toxicity) by using recently introduced platforms (multi-electrode array [MEA], patch clamp, cellular impedance, motion field imaging [MFI], and Ca transient systems) while identifying the strengths and weaknesses of each.
Our study (the first stage) showed that hiPS-CMs used in these platforms would offer paradigm changes of platforms for predicting drug-induced QT risk and/or arrhythmia or contractile dysfunction with a greater prognostic value beyond existing indirect surrogates proposed in animal models. I will introduce the latest progress and roadmap of activities of the CSAHi HEART Team (the second stage).

Teun de Boer, University of Utrecht:
Dynamic clamping on a Patchliner: adding virtual IK1 channels to cardiomyocytes"
Department of Medical Physiology, Division Heart & Lungs, University Medical Center Utrecht. Yalelaan 50, 3584 CM Utrecht, The Netherlands
t.p.deboer@umcutrecht.nl

Abstract:
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) are an interesting source of cells for safety pharmacology, but there are caveats that have to be taken into account. A typical property of hPSC-CM is automaticity, the cardiomyocytes beat spontaneously, resembling cells in the sinoatrial node of the heart. The spontaneous beating is due to lack of IK1 ion channels, which normally assure a stable resting membrane potential in cardiomyocytes. Work by our group has demonstrated that the depolarized state of hPSC-CM limits their usefulness in assays aimed at detecting proarrhythmic properties of drugs (Jonsson et al., 2012, PMID: 22353256).
Dynamic clamping can provide virtual, simulated IK1 channels to a real biological hPSC-CM in a patch clamping experiment. Key benefits of this approach include full control of the added IK1 conductance to each cardiomyocyte, it can be applied to any hPSC-CM source and it can be coupled to automated patch clamping machines. In this webinar I will discuss our work on using the dynamic clamping technique with a Patchliner.


The symposium is free to attend.
Download the program here.

Back to Overview

Contact Us

Please type your full name.
Invalid email address.
Invalid Input
Invalid Input
Nanion Technologies GmbH

Ganghoferstr. 70A
D-80339 Munich - Germany
info@nanion.de